Published in Arch Surg on April 01, 1998
Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction | NCT02703662
Long-term follow-up of a randomized controlled trial of suture versus mesh repair of incisional hernia. Ann Surg (2004) 6.14
Laparoscopic repair of ventral hernias: nine years' experience with 850 consecutive hernias. Ann Surg (2003) 4.70
A systematic review of the surgical treatment of large incisional hernia. Hernia (2014) 2.26
Primary closure of laparotomies with high risk of incisional hernia using prosthetic material: analysis of usefulness. Hernia (2003) 2.13
Long-term outcomes (>5-year follow-up) with porcine acellular dermal matrix (Permacol) in incisional hernias at risk for infection. Hernia (2013) 1.97
Laparoscopic incisional and ventral hernia repair: complications-how to avoid and handle. Hernia (2004) 1.78
Technical feasibility of robot-assisted ventral hernia repair. World J Surg (2012) 1.67
Laparoscopic versus open ventral hernia mesh repair: a prospective study. Surg Endosc (2006) 1.63
Intraperitoneal polypropylene mesh hernia repair complicates subsequent abdominal surgery. World J Surg (2007) 1.61
Choice of mesh for laparoscopic ventral hernia repair. Hernia (2007) 1.59
Desmoid tumors of the abdominal wall: A case report. World J Surg Oncol (2003) 1.53
Tensiometry as a decision tool for abdominal wall reconstruction with component separation. World J Surg (2009) 1.48
Prevention of incisional hernia in midline laparotomy with an onlay mesh: a randomized clinical trial. World J Surg (2014) 1.47
Decreased collagen type I/III ratio in patients with recurring hernia after implantation of alloplastic prostheses. Langenbecks Arch Surg (2003) 1.45
Prevention of adhesion to prosthetic mesh: comparison of different barriers using an incisional hernia model. Ann Surg (2003) 1.44
Prosthetic incisional hernioplasty: clinical experience with 354 cases. Hernia (2010) 1.43
The biology behind fascial defects and the use of implants in pelvic organ prolapse repair. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.42
Evaluation of new prosthetic meshes for ventral hernia repair. Surg Endosc (2006) 1.32
Major mesh-related complications following hernia repair: events reported to the Food and Drug Administration. Surg Endosc (2005) 1.32
Comparison of laparoscopic and open repair of incisional and primary ventral hernia: results of a prospective randomized study. Surg Endosc (2006) 1.31
A review of the composition, characteristics, and effectiveness of barrier mesh prostheses utilized for laparoscopic ventral hernia repair. Surg Endosc (2011) 1.29
Minimal adhesions to ePTFE mesh after laparoscopic ventral incisional hernia repair: reoperative findings in 65 cases. JSLS (2003) 1.27
Laparoscopic versus open umbilical hernia repair. JSLS (2003) 1.24
Laparoscopic incisional hernia repair: a review of the literature. Hernia (2006) 1.22
Hiatal hernia repair with mesh: a survey of SAGES members. Surg Endosc (2009) 1.21
Primary fascial closure with laparoscopic ventral hernia repair: systematic review. World J Surg (2014) 1.18
Incisional hernia: open techniques. World J Surg (2005) 1.18
Use of fibrin glue (Tissucol) in laparoscopic repair of abdominal wall defects: preliminary experience. Surg Endosc (2006) 1.18
Early biocompatibility of crosslinked and non-crosslinked biologic meshes in a porcine model of ventral hernia repair. Hernia (2011) 1.15
Experience with porcine acellular dermal collagen implant in one-stage tension-free reconstruction of acute and chronic abdominal wall defects. World J Surg (2007) 1.15
The analysis of infection after polypropylene mesh repair of abdominal wall hernia. World J Surg (2006) 1.13
Definitive surgical treatment of infected or exposed ventral hernia mesh. Ann Surg (2003) 1.11
Not all biologics are equal! Hernia (2010) 1.11
Prevention of adhesion formation to polypropylene mesh by collagen coating: a randomized controlled study in a rat model of ventral hernia repair. Surg Endosc (2004) 1.10
Open mesh repair of incisional hernia using a sublay technique: long-term follow-up. World J Surg (2008) 1.10
The prevention of incisional hernia formation using a delayed-release polymer of basic fibroblast growth factor. Ann Surg (2004) 1.09
Biologic versus nonbiologic mesh in ventral hernia repair: a systematic review and meta-analysis. World J Surg (2014) 1.07
Laparoscopic sutured closure with mesh reinforcement of incisional hernias. Hernia (2007) 1.07
Laparocopic ventral hernia repair with primary transparietal closure of the hernial defect. BMC Surg (2012) 1.06
Laparoscopic ventral hernia repair: a single center experience. Hernia (2006) 1.05
Prosthetic repair of incisional hernia in kidney transplant patients. A technique with onlay polypropylene mesh. Hernia (2001) 1.05
Laparoscopic ventral hernia repair: pros and cons compared with open hernia repair. JSLS (2008) 1.05
A comparative study of adhesion formation and abdominal wall ingrowth after laparoscopic ventral hernia repair in a porcine model using multiple types of mesh. Surg Endosc (2005) 1.05
Prospective histologic evaluation of intra-abdominal prosthetics four months after implantation in a rabbit model. Surg Endosc (2007) 1.03
Incisional hernia repair: laparoscopic techniques. World J Surg (2005) 1.03
Comparison of open and laparoscopic prosthetic repair of large ventral hernias. JSLS (2003) 1.03
Abdominal wall hernia repair: a comparison of Permacol and Surgisis grafts in a rat hernia model. Hernia (2008) 1.02
Recurrences in laparoscopic incisional hernia repairs: a personal series and review of the literature. JSLS (2000) 1.01
Ventral hernia repair using allogenic acellular dermal matrix in a swine model. Hernia (2004) 1.01
Eighty-five redo surgeries after 733 laparoscopic treatments for ventral and incisional hernia: adhesion and recurrence analysis. Hernia (2010) 1.01
Laparoscopic ventral hernia repair: does primary repair in addition to placement of mesh decrease recurrence? Surg Endosc (2011) 0.99
Intraperitoneal treatment of incisional and umbilical hernias using an innovative composite mesh: four-year results of a prospective multicenter clinical trial. Hernia (2004) 0.99
Minimally invasive component separation results in fewer wound-healing complications than open component separation for large ventral hernia repairs. J Am Coll Surg (2012) 0.99
Biologic versus Synthetic Mesh Reinforcement: What are the Pros and Cons? Clin Colon Rectal Surg (2014) 0.98
Outcome of laparoscopic ventral hernia repair in morbidly obese patients with a body mass index exceeding 35 kg/m2. Surg Endosc (2007) 0.98
Surgeon perspectives on options for ventral abdominal wall hernia repair: results of a postal questionnaire. Hernia (2005) 0.98
The effect of bacterial infection on the biomechanical properties of biological mesh in a rat model. PLoS One (2011) 0.97
Evaluation of implant/host tissue interactions following intraperitoneal implantation of porcine dermal collagen prosthesis in the rat. Hernia (2005) 0.97
Incisional hernia treatment with polypropylene graft: results of 10 years. Hernia (2006) 0.97
Enterocutaneous fistula associated with ePTFE mesh: case report and review of the literature. Hernia (2008) 0.97
What happens to the rectus abdominus fascia after laparoscopic ventral hernia repair? Hernia (2005) 0.97
Titanium coating of a polypropylene mesh for hernia repair: effect on biocompatibilty. Hernia (2004) 0.97
A critical review of biologic mesh use in ventral hernia repairs under contaminated conditions. Hernia (2013) 0.96
Adhesion formation after laparoscopic ventral incisional hernia repair with polypropylene mesh: a study using abdominal ultrasound. JSLS (2004) 0.95
Peritoneal adhesions to prosthetic materials: choice of mesh for incisional hernia repair. Surg Endosc (2000) 0.93
Abdominal wall desmoid tumors: A case report. Oncol Lett (2013) 0.93
Bacteriological analysis of meshes removed for complications after surgical management of urinary incontinence or pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.93
Mesh biocompatibility: effects of cellular inflammation and tissue remodelling. Langenbecks Arch Surg (2011) 0.93
No enterocutaneous fistula development in a cohort of 695 patients after incisional hernia repair using intraperitoneal uncoated polyproylene mesh. Hernia (2016) 0.92
Laparoscopic mesh repair of incisional hernia: an alternative to the conventional open repair? Hernia (2007) 0.92
Macrophage polarization in response to ECM coated polypropylene mesh. Biomaterials (2014) 0.92
An in vitro study assessing the effect of mesh morphology and suture fixation on bacterial adherence. Hernia (2013) 0.92
Infected large pore meshes may be salvaged by topical negative pressure therapy. Hernia (2012) 0.91
Biocompatibility of prosthetic meshes in abdominal surgery. Semin Immunopathol (2011) 0.91
Fibrin glue for intraperitoneal laparoscopic mesh fixation: a comparative study in a swine model. Surg Endosc (2010) 0.90
Laparoscopic transabdominal preperitoneal repair of ventral hernia: a step towards physiological repair. Indian J Surg (2011) 0.90
Laparoscopic incisional and ventral hernia repair. J Minim Access Surg (2007) 0.90
A prospective study between two different techniques for the repair of a large recurrent ventral hernia: a double mesh intraperitoneal repair versus onlay mesh repair. Hernia (2005) 0.90
Strength of tissue attachment to mesh after ventral hernia repair with synthetic composite mesh in a porcine model. Surg Endosc (2006) 0.90
Violation of the rectus complex is not a contraindication to component separation for abdominal wall reconstruction. J Am Coll Surg (2011) 0.90
Intraperitoneal tension-free repair of small midline ventral abdominal wall hernias with a Ventralex hernia patch: initial experience in 51 patients. Hernia (2006) 0.90
The suturing concept for laparoscopic mesh fixation in ventral and incisional hernias: preliminary results. Hernia (2003) 0.90
The omentum-polypropylene sandwich technique: an attractive method to repair large abdominal-wall defects in the presence of contamination or infection. Hernia (2006) 0.89
Outcomes of the Rives-Stoppa technique in incisional hernia repair: ten years of experience. Hernia (2006) 0.88
Milestones in the history of hernia surgery: prosthetic repair. Hernia (2003) 0.88
Patient satisfaction, chronic pain, and quality of life after elective incisional hernia repair: effects of recurrence and repair technique. Hernia (2010) 0.88
Development of novel electrospun absorbable polycaprolactone (PCL) scaffolds for hernia repair applications. Surg Endosc (2012) 0.88
The outcome of newborns with abdominal wall defects according to the method of abdominal closure: the experience of a single center. Pediatr Surg Int (2006) 0.87
Incisional hernia--comparison of mesh repair with Cardiff repair: an university hospital experience. Hernia (2005) 0.87
Impact of gentamicin-supplemented polyvinylidenfluoride mesh materials on MMP-2 expression and tissue integration in a transgenic mice model. Langenbecks Arch Surg (2010) 0.87
Cost analysis of incisional hernia repair by suture or mesh. Hernia (2003) 0.87
Immunohistochemical analysis of host reaction to heavyweight-, reduced-weight-, and expanded polytetrafluoroethylene (ePTFE)-based meshes after short- and long-term intraabdominal implantations. Surg Endosc (2008) 0.86
Laparoscopic repair of incisional and other complex abdominal wall hernias. Perm J (2009) 0.86
Different techniques for mesh application give the same abdominal muscle strength. Hernia (2010) 0.86
Polypropylene surgical mesh coated with extracellular matrix mitigates the host foreign body response. J Biomed Mater Res A (2013) 0.86
Mesh herniorrhaphy during elective colorectal surgery. Hernia (2004) 0.86
Current status of laparoscopic ventral hernia repair. Surg Endosc (2002) 0.86
Biocompatibility of bacterial contaminated prosthetic meshes and porcine dermal collagen used to repair abdominal wall defects. Langenbecks Arch Surg (2006) 0.85
Predicting in vivo responses to biomaterials via combined in vitro and in silico analysis. Tissue Eng Part C Methods (2014) 0.85
Carotid endarterectomy. Clinical results in a community-based teaching hospital. Stroke (1988) 2.77
Cytotoxic activity of lymphocytes. V. Role of soluble toxin in macrophage-inhibited cultures of tumor cells. J Immunol (1975) 1.88
Pneumococcal adherence to human epithelial cells. Infect Immun (1979) 1.82
Decreased skin-test reactivity associated with influenza. J Infect Dis (1972) 1.74
Serum factors responsible for killing of Shigella. Immunology (1974) 1.56
Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med (1980) 1.54
Classical and alternative complement pathway activation by pneumococci. Infect Immun (1977) 1.54
Complement system in pneumococcal infections. Infect Immun (1976) 1.50
Routine chest roentgenography is unnecessary in the work-up of stage I and II breast cancer. J Clin Oncol (2000) 1.50
Prolonged venous access for chemotherapy by means of the Hickman catheter. Cancer (1983) 1.49
Bacterial adherence: first step in pathogenesis of certain infections. J Chronic Dis (1978) 1.37
Intestinal immunoglobulins in shigellosis. Gastroenterology (1971) 1.33
Adherent microorganisms on lumenal surfaces of long-term intravenous catheters. Importance of Staphylococcus epidermidis in patients with cancer. Arch Intern Med (1986) 1.29
Adherence of group A streptococci to pharyngeal cells: a role in the pathogenesis of rheumatic fever. Science (1978) 1.25
Alternate-day prednisone therapy after renal transplantation. Lancet (1970) 1.25
Differences in etiology of pneumonias in nursing home and community patients. JAMA (1978) 1.18
Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis. Infect Immun (1977) 1.15
Reactions between certain strains of pneumococci and Fc of IgG. J Immunol (1974) 1.14
Model for studying bacterial adherence to epithelial cells infected with viruses. Infect Immun (1981) 1.12
Effect of indomethacin in vivo on humoral and cellular immunity in humans. Infect Immun (1978) 1.10
Delayed hypersensitivity skin testing. II. Clinical correlates and anergy. J Infect Dis (1974) 1.10
The unsatisfactory margin in breast cancer surgery. Am J Surg (1999) 1.09
Delayed hypersensitivity skin testing. I. Response rates in a hospitalized population. J Infect Dis (1974) 1.08
Reducing the pain of local anesthetic infiltration: warming and buffering have a synergistic effect. Ann Emerg Med (1994) 1.08
A prospective randomized study of sutured versus stapled bowel anastomoses in patients with cancer. Cancer (1986) 1.08
Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils. Immunology (1975) 1.08
Recurrent urinary tract infections in men. Characteristics and response to therapy. Ann Intern Med (1979) 1.07
Indolent pulmonary abscess associated with Klebsiella and Enterobacter. Am Rev Respir Dis (1973) 1.06
Effect of temperature on bacterial killing by serum and by polymorphonuclear leukocytes. Infect Immun (1977) 1.06
Bacterial meningitis in the absence of CSF pleocytosis. Arch Intern Med (1981) 1.04
Effect of immunization on the genesis of pneumococcal endocarditis in rabbits. Infect Immun (1981) 1.01
Two methods for improved venous access in acute leukemia patients. JAMA (1981) 1.00
Quantitative studies of the specificity of anti-pneumococcal polysaccharide antibodies, types 3 and 8. 3. Binding of a labeled oligosaccharide derived from S8 by anti-S8 antibodies. J Immunol (1968) 0.99
Antigens common to human and bacterial cells: urinary tract pathogens. J Lab Clin Med (1971) 0.98
Clinical features of plague in the United States: the 1969-1970 epidemic. J Infect Dis (1971) 0.98
Risk of dysphagia after transesophageal echocardiography during cardiac operations. Ann Thorac Surg (2000) 0.97
Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure. Am J Cardiol (1983) 0.97
Role of immunoglobulins in protection against Shigella-induced keratoconjunctives. Infect Immun (1975) 0.96
Ovarian carcinoma metastatic to breast: a case report and review of the literature. Gynecol Oncol (1990) 0.96
The 'primeless pump': a novel technique for intraoperative blood conservation. Cardiovasc Surg (1999) 0.95
Synergistic effect of basic fibroblast growth factor and methylprednisolone on neurological function after experimental spinal cord injury. J Neurosurg (1995) 0.94
Hip disarticulation for recurrent vulvar cancer in the groin. Gynecol Oncol (1992) 0.93
Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure. Clin Pharm (1985) 0.93
Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients. Am Heart J (1987) 0.93
Responses of isolated pulmonary arteries to synthetic peptide F-Met-Leu-Phe. Am J Physiol (1989) 0.92
Possible role of colonic content in the mucosal association of pathogenic shigella. Infect Immun (1980) 0.90
Male college students' compliance with testicular self-examination. J Adolesc Health Care (1989) 0.90
Hickman catheters in association with intensive cancer chemotherapy. Support Care Cancer (1993) 0.89
Bubonic plague in the Southwestern United States. A review of recent experience. Medicine (Baltimore) (1970) 0.89
p53 tumor suppressor oncogene expression in squamous cell carcinoma of the hypopharynx. Cancer (1994) 0.89
Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans. Undersea Hyperb Med (2002) 0.89
Role of antibody-coated bacteria in the management of urinary tract infections. South Med J (1977) 0.88
Use of extrafascially harvested radial artery for coronary artery revascularization: technical considerations. J Card Surg (2000) 0.88
Intestinal anastomosis after preoperative radiation therapy for carcinoma of the rectum. Surg Gynecol Obstet (1987) 0.87
A transient defect in leukocytic bactericidal capacity. Clin Immunol Immunopathol (1973) 0.87
An improved technique for the insertion of Hickman catheters in patients with thrombocytopenia and granulocytopenia. Surg Gynecol Obstet (1983) 0.87
Special studies of the Hickman catheter of a patient with recurrent bacteremia and candidemia. Am J Med Sci (1986) 0.86
Differences in blood group B-specific mucinase activity between virulent and avirulent Shigella flexneri 2a strains. Microb Pathog (1991) 0.86
Taste aversions in man. Am J Psychiatry (1974) 0.85
Endotoxin provocation of experimental renal cystic disease. Kidney Int (1987) 0.85
Resistance to infection of the external eye: the role of tears. Surv Ophthalmol (1979) 0.85
Antigens common to human and bacterial cells. IV. Studies of human pneumococcal disease. J Lab Clin Med (1974) 0.85
Corticosteroids, serum, and phagocytosis: in vitro and in vivo studies. Infect Immun (1974) 0.85
Long-term results and complications of preoperative radiation in the treatment of rectal cancer. Surgery (1988) 0.84
Effect of intravascular pneumococcal challenge on vascular permeability in rabbits. J Infect Dis (1983) 0.84
A surgery oral examination: interrater agreement and the influence of rater characteristics. Acad Med (1995) 0.84
Secretory IgA and direct killing of Shigella by serum components. Adv Exp Med Biol (1974) 0.84
Survival following moderate-dose preoperative radiation therapy for carcinoma of the rectum. Cancer (1985) 0.84
Pneumococcus-induced granulocytopenia and pulmonary leukostasis in rabbits. J Lab Clin Med (1981) 0.84
Estrogen receptors in bilateral breast cancer. Cancer (1988) 0.83
Comparison of 4% chlorhexidine gluconate in a detergent base (Hibiclens) and povidone-iodine (Betadine) for the skin preparation of hemodialysis patients and personnel. Am J Kidney Dis (1983) 0.83
Effect of intravenously injected killed pneumococci on leukocytes, complement, and phagocytosis in rabbits. Infect Immun (1980) 0.83
Intestinal immunoglobulins in shigellosis. Gastroenterology (1972) 0.83
Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis. J Clin Invest (1979) 0.83
The prognostic importance of steroid receptors in endometrial carcinoma. Obstet Gynecol (1988) 0.83
Nasal and cutaneous flora among hemodialysis patients and personnel: quantitative and qualitative characterization and patterns of Staphylococcal carriage. Am J Kidney Dis (1982) 0.83
Pneumococcal-induced pulmonary leukostasis and hemodynamic changes: role of complement and granulocytes. J Lab Clin Med (1984) 0.82
The therapeutic efficacy of hemodialysis in schizophrenia. N Engl J Med (1983) 0.82
A leak-free technique for open insertion of peritoneal dialysis catheters. Surg Gynecol Obstet (1983) 0.82
Early experiences in the treatment of falciparum malaria from Southeast Asia. JAMA (1968) 0.82
Influence of effective communication by surgery students on their oral examination scores. Acad Med (1991) 0.82
Diagnosis and thereapy of necrotizing soft tissue infections of the perineum. Ann Surg (1978) 0.81
Drug extravasation as a complication of venous access ports. Ann Intern Med (1985) 0.81
Urinary lactic dehydrogenase and serum C-reactive protein as means of localizing the site of urinary tract infection in patients with ileal conduits. J Urol (1982) 0.81
Immune complexes in infectious diseases. Adv Intern Med (1977) 0.81
Fluorescein Isothiocyanate-Labeled Lectin Analysis of the Surface of the Nitrogen-Fixing Bacterium Azospirillum brasilense by Flow Cytometry. Appl Environ Microbiol (1988) 0.81
Immunologic function in humans before and after hyperthermia and chemotherapy for disseminated malignancy. J Natl Cancer Inst (1977) 0.81
Angiogenic therapy for the chronically ischemic lower limb in a rabbit model. J Surg Res (2000) 0.81
Nasal and cutaneous Staphylococcus among patients receiving hemodialysis and attending personnel. J Infect Dis (1982) 0.81
Surgical management of pancreatic sarcoid. Eur J Surg (2001) 0.80
Gram-positive bacteria-induced granulocytopenia and pulmonary leukostasis in rabbits. Infect Immun (1982) 0.80
Access for hemodialysis by means of long-term central venous catheters. Kidney Int (1984) 0.80
Antigens common to human and bacterial cells. II. E. coli 014, the common Enterobacteriaceae antigen, blood groups A and B, and E. coli 086. J Lab Clin Med (1972) 0.80
Disseminated gonococcal infection: a case of beta-lactamase-producing Neisseria gonorrhoeae. J Am Podiatr Med Assoc (2000) 0.80
Indications and results of omental pedicle grafts in oncology. Cancer (1979) 0.79
Postoperative radiotherapy improves survival in squamous cell carcinoma of the hypopharynx. Am J Surg (1994) 0.79
Epidermal growth factor receptor expression in squamous cell carcinoma of the hypopharynx. Surg Oncol (1993) 0.79